Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WOROBEC, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WOROBEC, T.
(Chest. 1958;33:628-636.)
© 1958 American College of Chest Physicians

Blood Dyscrasias Associated with Antituberculosis and Combined Antituberculosis-Tranquilizing Chemotherapy

THOMAS WOROBEC M.D., F.C.C.P.1

1 Chief, NP-TB Service, Veterans Administration Hospital.

Two cases of hypersensitivity reaction to antituberculosis drugs are reported. With streptomycin and para-amino salicylic acid, one presented spiking fever, generalized erythematous dermatitis, lymphadenopathy, hepatitis with icterus, and a blood picture resembling infectious mononucleosis with leukemoid-lymphocytic reaction. Following desensitizing doses of streptomycin and PAS, the patient again showed evidence of toxicity to these drugs and also apparent cross-reaction with viomycin. He tolerated isoniazid, pyrazinamide, and the broad-spectrum antibiotics.

The other with PAS, isoniazid and chlorpromazine developed granulocytopenia, pleuropneumonia, and rapidly progressive circulatory failure attributed to bacterial toxemia, with no response to combined broad-spectrum antibiotics. The responsible drug or drugs could not be determined because of the rapidly fatal termination 26 hours after the onset of the acute illness.

Preliminary clinical observation does not specifically implicate one single or combination of drugs. Our clinical experience in the evaluation of the supplemental use of vitamins in correcting clinically suspected deficiencies has been favorable when a drug suspected of causing toxicity was resumed and apparently well tolerated.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1958 by the American College of Chest Physicians.